Skip to main content
TipRanks
Go Ultimate75% OFF

ROCHE HOLDING LTD Insider Profile

4 Followers

ROCHE HOLDING LTD, Ten Percent Owner at Jasper Therapeutics, holds 4.55M shares in Jasper Therapeutics (Ticker: JSPR), holds 2.81M shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 3.09M shares in Pandion Therapeutics (Ticker: PAND). Most recently, ROCHE HOLDING LTD Sold ― shares of Jasper Therapeutics on Jan 26, 2023 for an estimated value of $141.75K.

ROCHE HOLDING LTD's Trading History

JSPR
Jasper Therapeutics
Jan 26, 2023Ten Percent OwnerInformative Sell141.75K$53.55M
TRDA
Entrada Therapeutics Inc
Nov 04, 2021Ten Percent OwnerUninformative Buy―$14.07M
PAND
Pandion Therapeutics
Jul 23, 2020―Uninformative Buy―$185.32M
ALLK
Allakos
Jul 23, 2018―Uninformative Buy―$1.52M

You May Also Like

ROCHE HOLDING LTD insider profile FAQ

What stocks does ROCHE HOLDING LTD hold?
ROCHE HOLDING LTD holds: JSPR, ALLK, PAND, TRDA stocks.
What was ROCHE HOLDING LTD’s latest transaction?
ROCHE HOLDING LTD’s latest transaction was an Informative Sell of $141.75K.
What was ROCHE HOLDING LTD's most profitable transaction?
ROCHE HOLDING LTD’s most profitable transaction was an Informative Sell of JSPR stock on January 26, 2023. The return on the trade was 35.00%.
What is ROCHE HOLDING LTD's role in Jasper Therapeutics?
ROCHE HOLDING LTD's role in Jasper Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.